The effect of colistin treatment on the selection of colistin-resistant Escherichia coli in weaner pigs
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
The effect of colistin treatment on the selection of colistin-resistant Escherichia coli in weaner pigs. / Ahmed, Shahana; Hansen, Claus; Dahlkilde, Ane Laursen; Herrero-Fresno, Ana; Pedersen, Ken Steen; Nielsen, Jens Peter; Olsen, John Elmerdahl.
I: Antibiotics, Bind 10, Nr. 4, 465, 2021.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The effect of colistin treatment on the selection of colistin-resistant Escherichia coli in weaner pigs
AU - Ahmed, Shahana
AU - Hansen, Claus
AU - Dahlkilde, Ane Laursen
AU - Herrero-Fresno, Ana
AU - Pedersen, Ken Steen
AU - Nielsen, Jens Peter
AU - Olsen, John Elmerdahl
N1 - Funding Information: Funding: This study was funded by the Agriculture and Food Council, SEGES, Denmark (LD-32709-14-0017). Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021
Y1 - 2021
N2 - The treatment of diarrhea in the postweaning period is a common reason for the use of antimicrobials in pig production, and Escherichia coli is the single most important causative agent for this condition. Colistin has recently been classified as a critically important antimicrobial for human health, as it is a last-resort drug against certain multi-drug-resistant Gram-negative bacteria. Therefore, the use of colistin has been significantly reduced in some countries, including Denmark. Despite this, the drug is still commonly used to treat diarrhea in pigs in many countries, and there is a need to understand the risks associated with this practice. We performed a prospective cohort study to investigate the effect of colistin treatment on the changes in the average minimum inhibitory concentration (MIC) in commensal E. coli in a pig herd where no colistin-resistant bacteria were detectable before treatment. One group of pigs was batch treated with colistin after the clinical observation of diarrhea, one group was batch treated with colistin approximately 10 days before the expected onset of diarrhea, and a control group was not treated with colistin but provided with nonantimicrobial antidiarrheal feed supplement. Treatment with colistin in the dose and time combinations used did not result in a significant increase in the average colistin MIC values in E. coli. Moreover, no E. coli strains showed a MIC above the breakpoint of >2 mg/L against colistin. Co-selection of resistance to other antimicrobials was not observed.
AB - The treatment of diarrhea in the postweaning period is a common reason for the use of antimicrobials in pig production, and Escherichia coli is the single most important causative agent for this condition. Colistin has recently been classified as a critically important antimicrobial for human health, as it is a last-resort drug against certain multi-drug-resistant Gram-negative bacteria. Therefore, the use of colistin has been significantly reduced in some countries, including Denmark. Despite this, the drug is still commonly used to treat diarrhea in pigs in many countries, and there is a need to understand the risks associated with this practice. We performed a prospective cohort study to investigate the effect of colistin treatment on the changes in the average minimum inhibitory concentration (MIC) in commensal E. coli in a pig herd where no colistin-resistant bacteria were detectable before treatment. One group of pigs was batch treated with colistin after the clinical observation of diarrhea, one group was batch treated with colistin approximately 10 days before the expected onset of diarrhea, and a control group was not treated with colistin but provided with nonantimicrobial antidiarrheal feed supplement. Treatment with colistin in the dose and time combinations used did not result in a significant increase in the average colistin MIC values in E. coli. Moreover, no E. coli strains showed a MIC above the breakpoint of >2 mg/L against colistin. Co-selection of resistance to other antimicrobials was not observed.
KW - Antimicrobial resistance
KW - Colistin
KW - Commensal
KW - E. coli
KW - Pig diarrhea
U2 - 10.3390/antibiotics10040465
DO - 10.3390/antibiotics10040465
M3 - Journal article
C2 - 33923889
AN - SCOPUS:85105315972
VL - 10
JO - Antibiotics
JF - Antibiotics
SN - 2079-6382
IS - 4
M1 - 465
ER -
ID: 262800421